부산대학교 도서관

Hong, David S ; DuBois, Steven G ; Kummar, Shivaani ; Farago, Anna F ; Albert, Catherine M ; Rohrberg, Kristoffer S ; van Tilburg, Cornelis M ; Nagasubramanian, Ramamoorthy ; Berlin, Jordan D ; Federman, Noah ; Mascarenhas, Leo ; Geoerger, Birgit ; Dowlati, Afshin ; Pappo, Alberto S ; Bielack, Stefan ; Doz, François ; McDermott, Ray ; Patel, Jyoti D ; Schilder, Russell J ; Tahara, Makoto ; Pfister, Stefan M ; Witt, Olaf ; Ladanyi, Marc ; Rudzinski, Erin R ; Nanda, Shivani ; Childs, Barrett H ; Laetsch, Theodore W ; Hyman, David M ; Drilon, Alexander

In The Lancet Oncology April 2020 21(4):531-540

Apfelbaum AA; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Morin E; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.; Uppsala University Children's Hospital, Uppsala, Sweden.; Sturm D; Division of Pediatric Glioma Research, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Ayoub G; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; DiGiacomo J; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Bahadur S; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Chandarana B; Lady Davis Research Institute, Jewish General Hospital, Montreal, QC, Canada.; Department of Human Genetics, McGill University, Montreal, QC, Canada.; Power PC; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Cusick MM; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Novikov D; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Prabhakar P; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Jones RE; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Vogelzang J; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bossi CC; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Malinowski S; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Woodward LM; Blizard Institute, Queen Mary University of London, London, UK.; Jones TA; Blizard Institute, Queen Mary University of London, London, UK.; Jeang J; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Lamson SW; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Collins J; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Cai KY; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Jones JS; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Oh S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Jeon H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Wang J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Cameron A; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Rechter P; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; De Leon A; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Murugesan K; Computational Discovery, Foundation Medicine Inc, Boston, MA, USA.; Montesion M; Computational Discovery, Foundation Medicine Inc, Boston, MA, USA.; Albacker LA; Computational Discovery, Foundation Medicine Inc, Boston, MA, USA.; Ramkissoon SH; Pathology, Foundation Medicine Inc, Boston, MA, USA.; Labcorp Oncology, Durham, NC, USA.; Wake Forest Comprehensive Cancer Center and Department of Pathology, Winston-, Salem, NC, USA.; van Tilburg CM; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hardin EC; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Sievers P; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research, Heidelberg, Germany, Heidelberg, Germany.; Sahm F; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research, Heidelberg, Germany, Heidelberg, Germany.; Yeo KK; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Rosenberg T; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Chi SN; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Wright KD; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Hébert S; Lady Davis Research Institute, Jewish General Hospital, Montreal, QC, Canada.; Peck S; Orlando Health- Arnold Palmer Hospital for Children, Orlando, FL, USA.; Picca A; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau - Paris Brain Institute (ICM), AP-HP, Pitié Salpêtrière University Hospital, Paris, France.; Larouche V; Department of Pediatrics, Hemato-Oncology, CHU de Québec-Université Laval, Quebec City, QC, Canada.; Renzi S; Division of Pediatric Hematology-Oncology, Chul-Québec, Quebec City, QC, Canada.; Buhrlage SJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Bale TA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Smith AA; Orlando Health- Arnold Palmer Hospital for Children, Orlando, FL, USA.; Touat M; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau - Paris Brain Institute (ICM), AP-HP, Pitié Salpêtrière University Hospital, Paris, France.; Jabado N; Department of Human Genetics, McGill University, Montreal, QC, Canada.; Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Eck MJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Baird L; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Department of Neurosurgery, Harvard Medical School, Harvard University, Boston, MA, USA.; Witt O; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Kleinman CL; Lady Davis Research Institute, Jewish General Hospital, Montreal, QC, Canada.; Department of Human Genetics, McGill University, Montreal, QC, Canada.; Nguyen QD; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Sheer D; Blizard Institute, Queen Mary University of London, London, UK.; Alexandrescu S; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pathology, Boston Children's Hospital, Harvard University, Boston, MA, USA.; Jones DTW; Division of Pediatric Glioma Research, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Ligon KL; Broad Institute of MIT and Harvard, Cambridge, MA, USA. keith_ligon@dfci.harvard.edu.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. keith_ligon@dfci.harvard.edu.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. keith_ligon@dfci.harvard.edu.; Department of Pathology, Boston Children's Hospital, Harvard University, Boston, MA, USA. keith_ligon@dfci.harvard.edu.; Bandopadhayay P; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; In Process

Apfelbaum AA; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Morin E; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.; Uppsala University Children's Hospital, Uppsala, Sweden.; Sturm D; Division of Pediatric Glioma Research, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Ayoub G; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; DiGiacomo J; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Bahadur S; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Chandarana B; Lady Davis Research Institute, Jewish General Hospital, Montreal, QC, Canada.; Department of Human Genetics, McGill University, Montreal, QC, Canada.; Power PC; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Cusick MM; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Novikov D; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Prabhakar P; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Jones RE; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Vogelzang J; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bossi CC; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Malinowski S; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Woodward LM; Blizard Institute, Queen Mary University of London, London, UK.; Jones TA; Blizard Institute, Queen Mary University of London, London, UK.; Jeang J; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Lamson SW; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Collins J; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Cai KY; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Jones JS; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA.; Oh S; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Jeon H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Wang J; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Cameron A; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Rechter P; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; De Leon A; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Murugesan K; Computational Discovery, Foundation Medicine Inc, Boston, MA, USA.; Montesion M; Computational Discovery, Foundation Medicine Inc, Boston, MA, USA.; Albacker LA; Computational Discovery, Foundation Medicine Inc, Boston, MA, USA.; Ramkissoon SH; Pathology, Foundation Medicine Inc, Boston, MA, USA.; Labcorp Oncology, Durham, NC, USA.; Wake Forest Comprehensive Cancer Center and Department of Pathology, Winston-, Salem, NC, USA.; van Tilburg CM; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hardin EC; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Sievers P; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research, Heidelberg, Germany, Heidelberg, Germany.; Sahm F; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer Research, Heidelberg, Germany, Heidelberg, Germany.; Yeo KK; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Rosenberg T; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Chi SN; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Wright KD; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Hébert S; Lady Davis Research Institute, Jewish General Hospital, Montreal, QC, Canada.; Peck S; Orlando Health- Arnold Palmer Hospital for Children, Orlando, FL, USA.; Picca A; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau - Paris Brain Institute (ICM), AP-HP, Pitié Salpêtrière University Hospital, Paris, France.; Larouche V; Department of Pediatrics, Hemato-Oncology, CHU de Québec-Université Laval, Quebec City, QC, Canada.; Renzi S; Division of Pediatric Hematology-Oncology, Chul-Québec, Quebec City, QC, Canada.; Buhrlage SJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Bale TA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Smith AA; Orlando Health- Arnold Palmer Hospital for Children, Orlando, FL, USA.; Touat M; Sorbonne Université, Inserm, CNRS, UMR S 1127, Institut du Cerveau - Paris Brain Institute (ICM), AP-HP, Pitié Salpêtrière University Hospital, Paris, France.; Jabado N; Department of Human Genetics, McGill University, Montreal, QC, Canada.; Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Eck MJ; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.; Baird L; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA.; Department of Neurosurgery, Harvard Medical School, Harvard University, Boston, MA, USA.; Witt O; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Kleinman CL; Lady Davis Research Institute, Jewish General Hospital, Montreal, QC, Canada.; Department of Human Genetics, McGill University, Montreal, QC, Canada.; Nguyen QD; Lurie Family Imaging Center, Center for Biomedical Imaging in Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Sheer D; Blizard Institute, Queen Mary University of London, London, UK.; Alexandrescu S; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA.; Department of Pathology, Boston Children's Hospital, Harvard University, Boston, MA, USA.; Jones DTW; Division of Pediatric Glioma Research, Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Ligon KL; Broad Institute of MIT and Harvard, Cambridge, MA, USA. keith_ligon@dfci.harvard.edu.; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA, USA. keith_ligon@dfci.harvard.edu.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA. keith_ligon@dfci.harvard.edu.; Department of Pathology, Boston Children's Hospital, Harvard University, Boston, MA, USA. keith_ligon@dfci.harvard.edu.; Bandopadhayay P; Department of Pediatric Oncology, Dana-Farber Cancer/Boston Children's Cancer and Blood Disorders Center, Boston, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu.; Department of Pediatrics, Harvard Medical School, Harvard University, Boston, MA, USA. Pratiti_Bandopadhayay@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Filippidou M; Division of Pediatric Hematology-Oncology, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, Athens, Greece.; 'Aghia Sophia' Children's Hospital ERN-PeadCan Center, Athens, Greece.; Glentis S; Division of Pediatric Hematology-Oncology, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, Athens, Greece.; 'Aghia Sophia' Children's Hospital ERN-PeadCan Center, Athens, Greece.; Rigatou E; Division of Pediatric Hematology-Oncology, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, Athens, Greece.; 'Aghia Sophia' Children's Hospital ERN-PeadCan Center, Athens, Greece.; Sievers P; Hopp Children's Cancer Center, Heidelberg, Germany.; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Selt F; Hopp Children's Cancer Center, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Dimitriadis E; Department of Genetics, Aghios Savvas Hospital, Athens, Greece.; Perari P; Division of Pediatric Hematology-Oncology, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, Athens, Greece.; 'Aghia Sophia' Children's Hospital ERN-PeadCan Center, Athens, Greece.; Binenbaum I; Division of Pediatric Hematology-Oncology, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, Athens, Greece.; 'Aghia Sophia' Children's Hospital ERN-PeadCan Center, Athens, Greece.; Avgerinou G; Division of Pediatric Hematology-Oncology, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, Athens, Greece.; 'Aghia Sophia' Children's Hospital ERN-PeadCan Center, Athens, Greece.; van Tilburg CM; Hopp Children's Cancer Center, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Jones DTW; Hopp Children's Cancer Center, Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Sahm F; Hopp Children's Cancer Center, Heidelberg, Germany.; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Neuropathology, German Consortium for Translational Cancer research (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Milde T; Hopp Children's Cancer Center, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Pediatrics and Adolescent Medicine, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.; Witt O; Hopp Children's Cancer Center, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Pfister SM; Hopp Children's Cancer Center, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Grünewald TGP; Hopp Children's Cancer Center, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Stefanaki K; 'Aghia Sophia' Children's Hospital ERN-PeadCan Center, Athens, Greece.; Department of Pathology, 'Aghia Sophia' Children's Hospital, Athens, Greece.; Kattamis A; Division of Pediatric Hematology-Oncology, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, Athens, Greece.; 'Aghia Sophia' Children's Hospital ERN-PeadCan Center, Athens, Greece.

Publisher: John Wiley Country of Publication: United States NLM ID: 101186624 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1545-5017 (Electronic) Linking ISSN: 15455009 NLM ISO Abbreviation: Pediatr Blood Cancer Subsets: MEDLINE; In Process

Pfaff E; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Schramm K; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Blattner-Johnson M; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Jones BC; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Stark S; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Balasubramanian GP; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Previti C; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Core Facility Omics IT and Data Management (ODCF), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Autry RJ; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Fiesel P; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Sahm F; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Reuss D; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; von Deimling A; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; van Tilburg CM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Pajtler KW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Milde T; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatrics and Adolescent Medicine, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.; Dirksen U; Pediatrics III, West German Cancer Centre Essen, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK) partner site Essen, University Hospital Essen, Essen, Germany.; National Center for Tumor Diseases (NCT) partner site Essen, University Hospital Essen, Essen, Germany.; Kramm CM; Division of Pediatric Hematology and Oncology, University Medical Center Goettingen, Göttingen, Germany.; von Bueren AO; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Gynecology and Obstetrics, University Hospital of Geneva, Geneva, Switzerland.; Department of Pediatrics, Gynecology and Obstetrics, Faculty of Medicine, CANSEARCH Research Platform for Pediatric Oncology and Hematology, University of Geneva, Geneva, Switzerland.; Hutter C; Department of Pediatrics and Adolescent Medicine, St. Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.; de Wilde B; Pediatric Hematology and Oncology, Ghent University Hospital, Ghent, Belgium.; Molenaar J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Gerber NU; Department of Oncology and Children's Research Center, University Children's Hospital Zurich, Eleonoren Foundation, Zurich, Switzerland.; Lohi O; Faculty of Medicine and Health Technology, Tampere Center for Child, Adolescent and Maternal Health Research, Tampere University, Tampere, Finland.; Tays Cancer Center, Tampere University Hospital, Tampere, Finland.; Munthe-Kaas MC; Department of Pediatric Oncology and Hematology, Oslo University Hospital, Oslo, Norway.; Georgantzi K; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden.; Division of Pediatric Hematology-Oncology, Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.; Kazanowska B; Department of Pediatric Hematology/Oncology and BMT, University of Wroclaw, Wrocław, Poland.; Zápotocký M; Center for Pediatric Neuro-Oncology, Motol University Hospital, Prague, Czech Republic.; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.; Kattamis A; Division of Pediatric Hematology-Oncology, First Department of Pediatrics, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.; 'Aghia Sophia' Children's Hospital ERN-PeadCan Center, Athens, Greece.; Filippidou M; Division of Pediatric Hematology-Oncology, First Department of Pediatrics, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.; 'Aghia Sophia' Children's Hospital ERN-PeadCan Center, Athens, Greece.; Fried I; Pediatric Hemato-Oncology Unit, Wilf Children's Hospital, Shaare Zedek Medical Center, Jerusalem, Israel.; Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.; Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany. david.jones@kitz-heidelberg.de.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany. david.jones@kitz-heidelberg.de.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany. david.jones@kitz-heidelberg.de.

Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0412041 Publication Model: Electronic Cited Medium: Internet ISSN: 1432-0533 (Electronic) Linking ISSN: 00016322 NLM ISO Abbreviation: Acta Neuropathol Subsets: MEDLINE

Pfaff, Elke; Schramm, Kathrin; Blattner-Johnson, Mirjam; Jones, Barbara C; Stark, Sebastian; Balasubramanian, Gnana Prakash; Previti, Christopher; Autry, Robert J; Fiesel, Petra; Sahm, Felix; Reuss, David; von Deimling, Andreas; van Tilburg, Cornelis M; Pajtler, Kristian W; Milde, Till; Dirksen, Uta; Kramm, Christof M; Von Bueren, André; Munthe-Kaas, Monica C; Øra, Ingrid; Pfister, Stefan M; Witt, Olaf; Jones, David T W

Neurooncol Adv

Chirica M; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Jurmeister P; Institute of Pathology, Ludwig-Maximilians-University, Munich, Germany.; Teichmann D; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Koch A; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Perez E; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Schmid S; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Simon M; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, German HIT-LOGGIC-Registry for pLGG in Children and Adolescents, Berlin, Germany.; Driever PH; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, German HIT-LOGGIC-Registry for pLGG in Children and Adolescents, Berlin, Germany.; Bodden C; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; van Tilburg CM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, A Partnership Between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Hardin EC; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, A Partnership Between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Lavarino C; Laboratory of Molecular Oncology, Pediatric Cancer Center Barcelona, Hospital Sant Joan de Déu, Barcelona, Spain.; Hench J; Institute for Medical Genetics and Pathology, Division of Neuropathology, Universitätsspital Basel, Basel, Switzerland.; Scheie D; Department of Pathology, Rigshospitalet, Copenhagen, Denmark.; Cryan J; Department of Neuropathology, Beaumont Hospital, Dublin, Ireland.; Vicha A; Department of Paediatric Haematology and Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.; Buttarelli FR; Department of Radiological, Oncological and Anatomo-Pathological Sciences, Sapienza University, Rome, Italy.; Michiels A; Belgian Society for Pediatric Hematology and Oncology (BSPHO), Brussels, Belgium.; Department Pediatric Oncology, UZ Leuven, Leuven, Belgium.; Haberler C; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.; Barahona P; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Kensington, Australia.; Tops BBJ; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Jacques T; Department of Developmental Biology and Cancer, UCL GOS Institute of Child Health, University College London, London, UK.; Stokland T; Department of Pediatrics, Universitetssykehuset Nord-Norge, Tromso, Norway.; Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, A Partnership Between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, A Partnership Between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Berlin School of Integrative Oncology (BSIO), Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Capper D; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Publisher: Blackwell Scientific Publications Country of Publication: England NLM ID: 7609829 Publication Model: Print Cited Medium: Internet ISSN: 1365-2990 (Electronic) Linking ISSN: 03051846 NLM ISO Abbreviation: Neuropathol Appl Neurobiol Subsets: MEDLINE

O'Hare P; Department of Paediatric Oncology, Royal Belfast Hospital for Sick Children, Northern Ireland, UK.; Cooney T; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Broad Institute, Cambridge, Massachusetts, USA.; Day One Biopharmaceuticals, Boston, Massachusetts, USA.; de Blank P; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Broad Institute, Cambridge, Massachusetts, USA.; University of Cincinnati College of Medicine and Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Gutmann DH; Department of Neurology, Washington University School of Medicine, St. Louis, Missouri, USA.; Kieran M; Day One Biopharmaceuticals, Boston, Massachusetts, USA.; Milde T; Clinical Pediatric Oncology, Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center, National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Fangusaro J; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia, USA.; Fisher M; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.; Avula S; Department of Radiology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.; Packer R; Brain Tumor Institute, Center for Neuroscience and Behavioral Medicine, Children's National Hospital, Washington, District of Columbia, USA.; Fukuoka K; Department of Hematology/Oncology, Saitama Children's Medical Center, Saitama, Japan.; Mankad K; Department of Radiology, Great Ormond Street Hospital for Children NHS Foundation Trust, Department of Radiology, London, UK.; Mueller S; Department of Neurology, Neurosurgery and Pediatrics, University of California, San Francisco, San Francisco, California, USA.; Waanders AJ; Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.; Opocher E; Paediatric Haematology, Oncology and Stem Cell Transplant Division, Padua University Hospital, Padua, Italy.; Bouffet E; The Hospital for Sick Children and Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada.; Raabe E; Division of Pediatric Oncology, Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Werle NE; Pediatric Onco-Hematology Department, University Hospital of Strasbourg. UMR CNRS 7021, University of Strasbourg, Strasbourg, France.; Azizi AA; Department of Pediatrics and Adolescent Medicine and Comprehensive Centre of Pediatrics, Medical University of Vienna, Vienna, Austria.; Robison NJ; Division of Hematology & Oncology, Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, California, USA.; Hernáiz Driever P; Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, German HIT-LOGGIC-Registry for LGG in children and adolescents, Department of Pediatric Oncology/Hematology, Berlin, Germany.; Russo M; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.; Schouten N; Princess Maxima Center for Pediatric Oncology, Utrecht, Netherlands.; van Tilburg CM; Clinical Pediatric Oncology, Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center, National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Sehested A; Department of Paediatrics and Adolescent Medicine, The University Hospital Rigshospitalet, Copenhagen, Denmark.; Grill J; Department of Pediatric and Adolescent Oncology, Villejuif, France.; Bandopadhayay P; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts, USA.; Department of Pediatrics, Harvard Medical School, Broad Institute, Cambridge, Massachusetts, USA.; Kilday JP; The Centre for Paediatric, Teenage and Young Adult Cancer, Institute of Cancer Sciences, University of Manchester, and Royal Manchester Children's Hospital, Manchester, UK.; Witt O; Clinical Pediatric Oncology, Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Research Center, National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Ashley DM; Department of Neurosurgery, The Preston Robert Tisch Brain Tumor Center. Pediatric Neuro-Oncology, Preuss Laboratory for Brain Tumor Research, Durham, North Carolina, USA.; Ertl-Wagner BB; Department of Diagnostic Imaging, The Hospital for Sick Children, Toronto, Ontario, Canada.; Tabori U; The Hospital for Sick Children and Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada.; Hargrave DR; UCL Great Ormond Street Institute of Child Health, Great Ormond Street Hospital for Children, London, UK.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Langenberg, Karin P S; Meister, Michael T; Bakhuizen, Jette J; Boer, Judith M; van Eijkelenburg, Natasha K A; Hulleman, Esther; Ilan, Uri; Looze, Eleonora J; Dierselhuis, Miranda P; Lugt, Jasper van der; Breunis, Willemijn; Schild, Linda G; Ober, Kimberley; van Hooff, Sander R; Scheijde-Vermeulen, Marijn A; Hiemcke-Jiwa, Laura S; Flucke, Uta E; Kranendonk, Mariette E G; Wesseling, Pieter; Sonneveld, Edwin; Punt, Simone; Boltjes, Arjan; van Dijk, Freerk; Verwiel, Eugene T P; Volckmann, Richard; Hehir-Kwa, Jayne Y; Kester, Lennart A; Koudijs, Marco M J; Waanders, Esme; Holstege, Frank C P; Vormoor, H Josef; Hoving, Eelco W; Noesel, Max M van; Pieters, Rob; Kool, Marcel; Stumpf, Miriam; Blattner-Johnson, Mirjam; Balasubramanian, Gnana P; Van Tilburg, Cornelis M; Jones, Barbara C; Jones, David T W; Witt, Olaf; Pfister, Stefan M; Jongmans, Marjolijn C J; Kuiper, Roland P; de Krijger, Ronald R; Wijnen, Marc H W; den Boer, Monique L; Zwaan, C Michel; Kemmeren, Patrick; Koster, Jan; Tops, Bastiaan B J; Goemans, Bianca F; Molenaar, Jan J

Eur J Cancer

Wallin S; Division of Pediatric Oncology, Department of Women and Children´s Health, Karolinska Institutet, Stockholm, Sweden.; Øra I; Division of Pediatric Hematology-Oncology, Skåne University Hospital, & Clinical Sciences IKVL, Lund University, Lund, Sweden.; Prochazka G; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Sandgren J; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.; Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.; Björklund C; Division of Pediatric Hematology-Oncology, Umeå University Hospital, Umeå, Sweden.; Ljungman G; Department of Women and Children´s Health, Pediatric Hematology-Oncology Uppsala University, Uppsala, Sweden.; Vogt H; Division of Pediatric Hematology-Oncology B153, Crown Princess Victoria Children's Hospital, and Division of Children's and Women's Health, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Ek T; University of Gothenburg and Children´s Cancer Center, Sahlgrenska University Hospital, Gothenburg, Sweden.; van Tilburg CM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; German Cancer Consortium (DKTK), National Center for Tumor diseases (NCT), Heidelberg, Germany.; Nilsson A; Division of Pediatric Oncology, Department of Women and Children´s Health, Karolinska Institutet, Stockholm, Sweden.; Division of Pediatric Hematology-Oncology, Tema Barn, Astrid Lindgren Children's Hospital, Stockholm, Sweden.

Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE

van Tilburg, Cornelis M; Kilburn, Lindsay B; Perreault, Sébastien; Schmidt, Rene; Azizi, Amedeo A; Cruz-Martínez, Ofelia; Zápotocký, Michal; Scheinemann, Katrin; Meeteren, Antoinette YN Schouten-van; Sehested, Astrid; Opocher, Enrico; Driever, Pablo Hernáiz; Avula, Shivaram; Ziegler, David S; Capper, David; Koch, Arend; Sahm, Felix; Qiu, Jiaheng; Tsao, Li-Pen; Blackman, Samuel C; Manley, Peter; Milde, Till; Witt, Ruth; Jones, David TW; Hargrave, Darren; Witt, Olaf

BMC Cancer
BMC Cancer, Vol 24, Iss 1, Pp 1-11 (2024)

Okonechnikov K; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Joshi P; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Developmental Origins of Pediatric Cancer Junior Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Körber V; Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; MRC Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.; Rademacher A; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.; Bortolomeazzi M; Single-cell Open Lab, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Mallm JP; Single-cell Open Lab, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Vaillant J; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Developmental Origins of Pediatric Cancer Junior Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; da Silva PBG; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Developmental Origins of Pediatric Cancer Junior Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Statz B; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Sepp M; Center for Molecular Biology of Heidelberg University (ZMBH), DKFZ-ZMBH Alliance, Heidelberg, Germany.; Sarropoulos I; Center for Molecular Biology of Heidelberg University (ZMBH), DKFZ-ZMBH Alliance, Heidelberg, Germany.; Yamada T; Center for Molecular Biology of Heidelberg University (ZMBH), DKFZ-ZMBH Alliance, Heidelberg, Germany.; Wittmann A; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Schramm K; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Blattner-Johnson M; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Fiesel P; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; CCU Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Jones B; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Jäger N; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Milde T; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Pajtler KW; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.; van Tilburg CM; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Witt O; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.; CCU Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Bochennek K; Frankfurt University Hospital, Goethe University, Frankfurt, Germany.; Weber KJ; Goethe University Frankfurt, University Hospital, Neurological Institute (Edinger Institute), Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Heidelberg, Germany and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.; Goethe University Frankfurt, University Hospital, University Cancer Center (UCT) Frankfurt, Frankfurt am Main, Germany.; Nonnenmacher L; University Children's Hospital, Ulm, Germany.; Reimann C; University Children's Hospital, Ulm, Germany.; Ghasemi DR; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Schüller U; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Department of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Mynarek M; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Rutkowski S; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Jones DTW; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Korshunov A; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; CCU Neuropathology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Rippe K; Division of Chromatin Networks, German Cancer Research Center (DKFZ) and Bioquant, Heidelberg, Germany.; Westermann F; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Thongjuea S; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Höfer T; Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Kaessmann H; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Kutscher LM; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany. l.kutscher@kitz-heidelberg.de.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany. l.kutscher@kitz-heidelberg.de.; Developmental Origins of Pediatric Cancer Junior Research Group, German Cancer Research Center (DKFZ), Heidelberg, Germany. l.kutscher@kitz-heidelberg.de.; Pfister SM; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany. s.pfister@kitz-heidelberg.de.; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany. s.pfister@kitz-heidelberg.de.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany. s.pfister@kitz-heidelberg.de.; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany. s.pfister@kitz-heidelberg.de.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Fischer TT; Heidelberg Biosciences International Graduate School (HBIGS), Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg Faculty of Medicine, Heidelberg University, Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Maass KK; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg Faculty of Medicine, Heidelberg University, Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Schoof M; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Puranachot P; Princess Srisavangavadhana Faculty of Medicine, Chulabhorn Royal Academy, Bangkok, Thailand.; Sievers P; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neuropathology, Heidelberg University Hospital, Heidelberg Faculty of Medicine, Heidelberg University, Heidelberg, Germany.; Montigel S; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Fluhr T; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg Faculty of Medicine, Heidelberg University, Heidelberg, Germany.; El Damaty A; Department of Neurosurgery, Heidelberg University Hospital, Heidelberg Faculty of Medicine, Heidelberg University, Heidelberg, Germany.; Seitz A; Department of Neuroradiology, Heidelberg University Hospital, Heidelberg Faculty of Medicine, Heidelberg University, Heidelberg, Germany.; Harrabi S; Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg Faculty of Medicine, Heidelberg University, Heidelberg, Germany.; Schramm K; Division of Pediatric Glioma Research, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Sturm D; Division of Pediatric Glioma Research, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg Faculty of Medicine, Heidelberg University, Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Jones DTW; Division of Pediatric Glioma Research, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Pfister SM; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg Faculty of Medicine, Heidelberg University, Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Witt O; Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg Faculty of Medicine, Heidelberg University, Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; van Tilburg CM; Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg Faculty of Medicine, Heidelberg University, Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Milde T; Comprehensive Cancer Center Central Germany (CCCG), Jena, Germany.; Department of Pediatrics and Adolescent Medicine, Friedrich Schiller University Jena, University Hospital Jena, Jena, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Schüller U; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Pajtler KW; National Center for Tumor Diseases (NCT), NCT Heidelberg, a partnership between DKFZ and Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Heidelberg Faculty of Medicine, Heidelberg University, Heidelberg, Germany.; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.

Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

Desai AV; Department of Pediatrics, Section of Hematology/Oncology/Stem Cell Transplantation, University of Chicago Medical Center, 5721 S. Maryland Ave., Chicago, IL 60637, USA. Electronic address: adesai12@bsd.uchicago.edu.; Bagchi A; Division of Neuro-Oncology, Department of Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS 260, Memphis, TN 38105, USA. Electronic address: aditi.bagchi@stjude.org.; Armstrong AE; Division of Pediatric Hematology/Oncology, Washington University School of Medicine in St. Louis, 660 S. Euclid Ave., St. Louis, MO 63110-1010, USA. Electronic address: armstrongae@wustl.edu.; van Tilburg CM; Hopp Children's Cancer Center Heidelberg, Im Neuenheimer Feld 430, Heidelberg 69120, Germany; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg 69120, Germany; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Im Neuenheimer Feld 672, Heidelberg 69120, Germany; German Cancer Consortium, Im Neuenheimer Feld 280, Heidelberg 69120, Germany; National Center for Tumor Diseases, Im Neuenheimer Feld 460, Heidelberg 69120, Germany. Electronic address: cornelis.vantilburg@med.uni-heidelberg.de.; Basu EM; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA. Electronic address: basue@mskcc.org.; Robinson GW; Division of Neuro-Oncology, Department of Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS 260, Memphis, TN 38105, USA. Electronic address: giles.robinson@stjude.org.; Wang H; Department of Oncology Surgery, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, 56 Nanlishi Rd, Xicheng District, Beijing 100045, China. Electronic address: wanghuanmin@bch.com.cn.; Casanova M; Pediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, via Giacomo Venezian, Milan 1 20133, Italy. Electronic address: michela.casanova@istitutotumori.mi.it.; André N; Pediatric Hematology and Oncology Department, Hôpital pour Enfant de La Timone, AP-HM, 264 Rue Saint-Pierre, Marseille 13005, France; Reverse Molecular Pharmacology for Pediatric Oncology, Centre de Recherche en Cancérologie de Marseille Inserm U1068, Aix-Marseille University, 27 Bd Lei Roure, Marseille 13009, France. Electronic address: Nicolas.ANDRE@ap-hm.fr.; Campbell-Hewson Q; Department of Paediatric Haematology, Oncology and Bone Marrow Transplantation, Great North Children's Hospital, Victoria Wing, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, UK. Electronic address: Quentin.CampbellHewson@nhs.net.; Wu Y; Department of Pediatric Surgery, Xinhua Hospital, Affiliated to Shanghai Jiaotong University School of Medicine, 1665 Kongjiang Rd, Shanghai 200092, China. Electronic address: wuymsh@163.com.; Cardenas A; Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA (†formerly). Electronic address: alisong@gene.com.; Ci B; Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA (†formerly). Electronic address: cib1@gene.com.; Ryklansky C; Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA (†formerly). Electronic address: carolryk@yahoo.com.; Devlin CE; Roche Products Ltd, Hexagon Place, Shire Park, Falcon Way, Welwyn Garden City, AL7 1TW, UK. Electronic address: clare.devlin@roche.com.; Meneses-Lorente G; Roche Products Ltd, Hexagon Place, Shire Park, Falcon Way, Welwyn Garden City, AL7 1TW, UK. Electronic address: georgina.meneses-lorente@roche.com.; Wulff J; Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA (†formerly). Electronic address: wulff.jade@gene.com.; Hutchinson KE; Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA (†formerly). Electronic address: hutchinson.katherine@gene.com.; Gajjar A; Division of Neuro-Oncology, Department of Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, MS 260, Memphis, TN 38105, USA. Electronic address: amar.gajjar@stjude.org.; Fox E; Department of Oncology, St. Jude Children's Research Hospital, 262 Danny Thomas Pl, Memphis, TN 38105, USA. Electronic address: Elizabeth.Fox@stjude.org.

Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE

Selt F; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany. f.selt@kitz-heidelberg.de.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany. f.selt@kitz-heidelberg.de.; Clinical Trial Unit (ZIPO), Department of Pediatric Hematology, Oncology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany. f.selt@kitz-heidelberg.de.; National Center for Tumor Diseases (NCT), Heidelberg, Germany. f.selt@kitz-heidelberg.de.; Sigaud R; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Pediatrics and Adolescent Medicine, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.; Comprehensive Cancer Center Central Germany (CCCG), Jena, Germany.; Korshunov A; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Capper D; Department of Neuropathology, Charité - Universitätsmedizin Berlin, Campus Charité Mitte, German Consortium for Translational Cancer Research (DKTK), Berlin, Germany.; Reuss D; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; von Deimling A; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Pajtler KW; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Clinical Trial Unit (ZIPO), Department of Pediatric Hematology, Oncology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; van Tilburg CM; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Clinical Trial Unit (ZIPO), Department of Pediatric Hematology, Oncology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Nesper-Brock M; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Clinical Trial Unit (ZIPO), Department of Pediatric Hematology, Oncology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Sahm F; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Department of Neuropathology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Clinical Trial Unit (ZIPO), Department of Pediatric Hematology, Oncology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Milde T; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Department of Pediatrics and Adolescent Medicine, University Hospital Jena, Friedrich Schiller University Jena, Jena, Germany.; Comprehensive Cancer Center Central Germany (CCCG), Jena, Germany.; Ecker J; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Clinical Trial Unit (ZIPO), Department of Pediatric Hematology, Oncology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Mascarenhas L; Cedars Sinai Medical Center, Los Angeles, CA.; DuBois SG; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, MA.; Albert CM; Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Center, Seattle, WA.; Bielack S; Pädiatrie 5 (Onkologie, Hämatologie, Immunologie), Zentrum für Kinder-, Jugend- und Frauenmedizin, Stuttgart Cancer Center, Klinikum Stuttgart-Olgahospital, Stuttgart, Germany.; Orbach D; SIREDO Oncology Center (Care, Innovation and Research for Children, Adolescents and Young Adults with Cancer), Institut Curie, PSL University, Paris, France.; Federman N; David Geffen School of Medicine, University of California, Los Angeles, CA.; Geoerger B; Gustave Roussy Cancer Center, Department of Pediatric and Adolescent Oncology, INSERM U1015, Université Paris-Saclay, Villejuif, France.; Nagasubramanian R; Nemours Children's Hospital, Orlando, FL.; Zhang Y; Sun Yat-sen University Cancer Center, Guangzhou, China.; Chisholm J; Children and Young Peoples Unit, Royal Marsden Hospital and Institute of Cancer Research, Sutton, United Kingdom.; Gallego Melcon S; Pediatric Oncology and Hematology, Vall d'Hebron Children's Hospital, Barcelona, Spain.; Goto H; Kanagawa Children's Medical Center, Yokohama, Japan.; Morgenstern DA; Hospital for Sick Children and University of Toronto, Toronto, ON, Canada.; Owens C; Department of Haemato-Oncology, Our Lady's Children's Hospital, Dublin, Ireland.; Pappo AS; St Jude Children's Research Hospital, Memphis, TN.; Perreault S; Department of Neurosciences, CHU Sainte Justine, Montreal, QC, Canada.; Schulte JH; Charité-Universitätsmedizin Berlin, Berlin, Germany.; Department of Pediatric Hematology and Oncology, University Children's Hospital, Eberhard Karls University Tuebingen, Tuebingen, Germany.; Shukla N; Memorial Sloan Kettering Cancer Center, New York, NY.; Zwaan CM; Princess Máxima Centre, Utrecht, the Netherlands.; Erasmus MC, Rotterdam, the Netherlands.; Neu N; Chrestos Concept GmbH & Co, KG, Essen, Germany.; Bernard-Gauthier V; Bayer Pharmaceuticals, Inc., Toronto, Canada.; De La Cuesta E; Bayer HealthCare Pharmaceuticals, Inc, Whippany, NJ.; van Tilburg CM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center für Tumor Disease (NCT), Heidelberg, Germany.; Laetsch TW; Children's Hospital of Philadelphia/University of Pennsylvania, Philadelphia, PA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Mascarenhas L; DuBois SG; Albert CM; Bielack S; Orbach D; Federman N; Geoerger B; Nagasubramanian R; Zhang Y; Chisholm J; Melcon SG; Goto H; Morgenstern DA; Owens C; Pappo AS; Perreault S; Schulte JH; Shukla N; Zwaan CM; Neu N; Bernard-Gauthier V; De La Cuesta E; van Tilburg CM; Laetsch TW

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE; PubMed not MEDLINE

van Tilburg, Cornelis M; Pfaff, Elke; Pajtler, Kristian W; Langenberg, Karin P S; Fiesel, Petra; Jones, Barbara C; Balasubramanian, Gnana Prakash; Stark, Sebastian; Johann, Pascal D; Blattner-Johnson, Mirjam; Schramm, Kathrin; Dikow, Nicola; Hirsch, Steffen; Sutter, Christian; Grund, Kerstin; von Stackelberg, Arend; Kulozik, Andreas E; Lissat, Andrej; Borkhardt, Arndt; Meisel, Roland; Reinhardt, Dirk; Klusmann, Jan-Henning; Fleischhack, Gudrun; Tippelt, Stephan; von Schweinitz, Dietrich; Schmid, Irene; Kramm, Christof M; von Bueren, André O; Calaminus, Gabriele; Vorwerk, Peter; Graf, Norbert; Westermann, Frank; Fischer, Matthias; Eggert, Angelika; Burkhardt, Birgit; Wößmann, Wilhelm; Nathrath, Michaela; Hecker-Nolting, Stefanie; Frühwald, Michael C; Schneider, Dominik T; Brecht, Ines B; Ketteler, Petra; Fulda, Simone; Koscielniak, Ewa; Meister, Michael T; Scheer, Monika; Hettmer, Simone; Schwab, Matthias; Tremmel, Roman; Molenaar, Jan J

Cancer Discovery. 11(11):2764-2779

Kolodziejczak AS; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; CCU Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Guerrini-Rousseau L; Department of Children and Adolescents Oncology, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.; Molecular Predictors and New Targets in Oncology, Inserm U981 Team 'Genomics and Oncogenesis of pediatric Brain Tumors,' Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Planchon JM; Department of Diagnostic and Theranostic Medicine, Somatic Genetics Unit, Institut Curie, Paris-Science Lettres University, Paris, France.; Ecker J; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; CCU Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Selt F; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; CCU Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Mynarek M; Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Mildred Scheel Cancer Career Center HaTriCS4, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Obrecht D; Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Sill M; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Autry RJ; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Stutheit-Zhao E; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Princess Margaret Cancer Centre, Toronto, Ontario, Canada.; Hirsch S; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Amouyal E; SIREDO Pediatric Oncology Center, Institut Curie, Paris-Science Lettres University, Paris, France.; Dufour C; Department of Children and Adolescents Oncology, Gustave Roussy, Université Paris-Saclay, 94805 Villejuif, France.; Molecular Predictors and New Targets in Oncology, Inserm U981 Team 'Genomics and Oncogenesis of pediatric Brain Tumors,' Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Ayrault O; Institut Curie, PSL Research University, CNRS UMR, INSERM, Orsay, France Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay, France.; Torrejon J; Institut Curie, PSL Research University, CNRS UMR, INSERM, Orsay, France Université Paris Sud, Université Paris-Saclay, CNRS UMR 3347, INSERM U1021, Orsay, France.; Waszak SM; Centre for Molecular Medicine Norway (NCMM), Nordic EMBL Partnership, University of Oslo and Oslo University Hospital, Oslo, Norway.; Department of Neurology, University of California, San Francisco, CA, USA.; Ramaswamy V; Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada.; Division of Hematology and Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.; Pentikainen V; Division of Hematology-Oncology and Stem Cell Transplantation, Children's Hospital, Helsinki University Hospital, Helsinki, Finland.; Demir HA; Department of Pediatric Hematology-Oncology, Private Memorial Ankara Hospital, Ankara, Turkey.; Clifford SC; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, United Kingdom.; Schwalbe EC; Wolfson Childhood Cancer Research Centre, Newcastle University Centre for Cancer, Newcastle upon Tyne, United Kingdom.; Applied Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom.; Massimi L; Pediatric Neurosurgery, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University Medical School, Rome, Italy.; Snuderl M; Department of Pathology, New York University Langone Health, New York City, NY, USA.; Galbraith K; Department of Pathology, New York University Langone Health, New York City, NY, USA.; Karajannis MA; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Hill K; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Li BK; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; Walsh M; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York City, NY, USA.; White CL; Victorian Clinical Genetics Services, Parkville, Australia.; Hudson Institute of Medical Research, Clayton, Australia.; Department of Molecular and Translational Science, Monash University, Clayton, Australia.; Redmond S; Childhood Cancer Registry, Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Loizos L; Pediatric Oncology/Hematology/Immunology at the Medical School of the University of Nicosia, Nicosia, Cyprus.; Jakob M; Department of Paediatric Haematology, Oncology and Stem-Cell Transplantation, University Hospital Regensburg, Regensburg, Germany.; Kordes UR; Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Schmid I; Paediatric Haematology and Oncology, Dr. von Hauner Children's Hospital, Ludwig Maximilians University Munich, Munich, Germany.; Hauer J; Pediatric Haematology and Oncology, University Hospital Carl Gustav Carus, Dresden, Germany.; Blattmann C; Paediatric Haematology, Oncology and Immunology, Olgahospital, Klinikum Stuttgart, Stuttgart, Germany.; Filippidou M; Division of Pediatric Hematology-Oncology, First Department of Pediatrics, National and Kapodistrian University of Athens, 'Aghia Sophia' Children's Hospital, Athens, Greece.; Piccolo G; Neuro-Oncology Unit, IRCCS Istituto Giannina Gaslini, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa, Italy.; Scheurlen W; Paediatric Haematology and Oncology, Cnopfsche Paediatric Clinic, Nurnberg, Germany.; Farrag A; Department of Paediatric Haematology, Oncology and Stem-Cell Transplantation, Paediatric Clinic, University Hospital Aachen, Aachen, Germany.; Department of Pediatric Oncology, South Egypt Cancer Institute, Assiut University, Egypt.; Grund K; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.; Sutter C; Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.; Pietsch T; Institute of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn Medical Center, Bonn, Germany.; Frank S; Division of Neuropathology, Institute of Pathology, Basel University Hospital, Basel, Switzerland.; Schewe DM; Department of Pediatrics, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.; Malkin D; Division of Hematology/Oncology, Department of Pediatrics, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.; Ben-Arush M; Pediatric Hematology Oncology, Rambam Medical Center, Haifa, Israel.; Sehested A; Department of Paediatrics and Adolescent Medicine, Juliane Marie Centre, Copenhagen University Hospital, Copenhagen, Denmark.; Wong TT; Division of Pediatric Neurosurgery, Department of Neurosurgery, Taipei Medical University Hospital, Taipei Medical University, Taipei 110, Taiwan.; Wu KS; Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Liu YL; Department of Pediatrics, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.; Carceller F; Paediatric and Adolescent Oncology Drug Development Team, Children and Young People's Unit, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, Sutton, United Kingdom.; Mueller S; Department of Neurology, Neurosurgery and Pediatrics, University of California, San Francisco, USA.; Stoller S; Department of Neurology, University of California, San Francisco, USA.; Taylor MD; Division of Neurosurgery, Program in Developmental and Stem Cell Biology, Arthur and Sonia Labatt Brain Tumour Research Centre, Hospital for Sick Children, Toronto, Ontario, Canada.; Tabori U; Division of Hematology and Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.; Bouffet E; Division of Hematology and Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.; The Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON M5G 1X8, Canada; Division of Haematology/ Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.; Kool M; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Sahm F; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, and CCU Neuropathology, German Cancer Institute (DKF), Heidelberg, Germany.; von Deimling A; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, and CCU Neuropathology, German Cancer Institute (DKF), Heidelberg, Germany.; Korshunov A; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, and CCU Neuropathology, German Cancer Institute (DKF), Heidelberg, Germany.; von Hoff K; Department of Pediatric Oncology and Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark.; Kratz CP; Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.; Sturm D; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Jones DTW; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Rutkowski S; Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; van Tilburg CM; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; CCU Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Witt O; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; CCU Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Bougeard G; Univ Rouen Normandie, Inserm U1245 and CHU Rouen, Department of Genetics, F-76000 Rouen, France.; Pajtler KW; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Pfister SM; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Pediatric Neurooncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Bourdeaut F; SIREDO Pediatric Oncology Center, Institut Curie, Paris-Science Lettres University, Paris, France.; Milde T; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.; CCU Pediatric Oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

Hardin EC; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK).; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Medical Faculty, University of Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Schmid S; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Sommerkamp A; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Paediatrics and Adolescent Medicine, The University Hospital Rigshospitalet, Copenhagen, Denmark.; Bodden C; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK).; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Heipertz AE; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK).; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; Heidelberg Medical Faculty, University of Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Sievers P; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Wittmann A; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Milde T; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK).; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; von Deimling A; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, Saint Luc University Hospital, Brussels, Belgium.; Horn S; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, HIT-LOGGIC German Registry for children and adolescents with low-grade glioma, Berlin, Germany.; Herz NA; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, HIT-LOGGIC German Registry for children and adolescents with low-grade glioma, Berlin, Germany.; Simon M; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, HIT-LOGGIC German Registry for children and adolescents with low-grade glioma, Berlin, Germany.; Department of Pediatric Oncology/Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Perera AA; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Heidelberg Medical Faculty, University of Heidelberg, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Azizi A; Division of Neonatology, Pediatric Intensive Care and Neuropediatrics, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.; Cruz O; Neuro-Oncology Unit, Pediatric Cancer Center, Hospital Sant Joan de Deu, Barcelona, Spain.; Curry S; Department of Haematology and Oncology, Children's Health Ireland at Crumlin, Dublin, Ireland.; Van Damme A; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Department of Pediatric Hematology and Oncology, Saint Luc University Hospital, Brussels, Belgium.; Garami M; 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.; Hargrave D; Great Ormond Street Hospital for Children NHS Trust London, London, UK.; Kattamis A; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; First Department of Paediatrics, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.; Kotnik BF; Department of Haematology and Oncology, University Children's Hospital, University Medical Centre Ljubljana (UMC), Ljubljana, Slovenia.; Lähteenmäki P; Turku University and University Hospital, Turku, Finland.; Swedish Childhood Cancer Registry, Karolinska Institutet, Stockholm, Sweden.; Scheinemann K; Division of Pediatric Oncology - Hematology, Department of Pediatrics, Kantonsspital Aarau, Aarau, Switzerland.; Department of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.; Department of Paediatrics, McMaster Children's Hospital and McMaster University, Hamilton, Canada.; Schouten-van Meeteren AYN; Department of Pediatric Oncology, Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands.; Sehested A; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Paediatrics and Adolescent Medicine, The University Hospital Rigshospitalet, Copenhagen, Denmark.; Viscardi E; Pediatric Oncology Unit, Padova University, Padova, Italy.; Wormdal OM; Section of Pediatric Oncology, UNN University Hospital of Northern Norway, Tromsø, Norway.; Zapotocky M; Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, University Hospital Motol, Charles University, Prague, Czech Republic.; Ziegler DS; Kids Cancer Centre, Sydney Children's Hospital, High St, Randwick, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, Sydney, Australia.; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Sydney, NSW, Australia.; Koch A; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; First Department of Paediatrics, 'Aghia Sophia' Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.; Hernáiz Driever P; Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, HIT-LOGGIC German Registry for children and adolescents with low-grade glioma, Berlin, Germany.; Department of Pediatric Oncology/Hematology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK).; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Capper D; Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Sahm F; Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.; Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.; van Tilburg CM; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; German Cancer Consortium (DKTK).; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany.

Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE